Drug Delivery Stocks List
Symbol | Grade | Name | % Change |
---|---|---|---|
BDSI | F | BioDelivery Sciences International, Inc. | 0.75 |
DRRX | F | DURECT Corporation | 0.99 |
PCRX | C | Pacira Pharmaceuticals, Inc. | 2.95 |
SRDX | A | SurModics, Inc. | 2.42 |
BDX | D | Becton, Dickinson and Company | 2.31 |
HTGC | B | Hercules Technology Growth Capital, Inc. | -5.40 |
LDL | B | Lydall, Inc. | 2.17 |
MDT | A | Medtronic Inc. | 2.59 |
MMM | A | 3M Company | 1.78 |
WST | F | West Pharmaceutical Services, Inc. | 1.99 |
HRTX | D | Heron Therapeutics, Inc. | 3.19 |
DRNA | B | Dicerna Pharmaceuticals, Inc. | 1.26 |
EARS | C | Auris Medical Holding AG | 12.46 |
EYEG | D | Eyegate Pharmaceuticals, Inc. | 3.45 |
NEOS | C | Neos Therapeutics, Inc. | 0.22 |
TTNP | F | Titan Pharmaceuticals, Inc. | -2.78 |
TPVY | D | TriplePoint Venture Growth BDC Corp. 5.75% Notes due 2022 | 0.00 |
TLC | F | Taiwan Liposome Company, Ltd. | 0.61 |
LCTX | D | Lineage Cell Therapeutics, Inc. | -0.54 |
PROG | F | Progenity, Inc. | -1.48 |
LEXX | F | Lexaria Bioscience Corp. | -0.55 |
VRPX | F | Virpax Pharmaceuticals, Inc. | -1.40 |
Symbol | Grade | Name | Weight |
---|---|---|---|
IHI | D | iShares U.S. Medical Devices ETF | 15.03 |
IEHS | D | iShares Evolved U.S. Healthcare Staples ETF | 8.62 |
FLV | A | American Century Focused Large Cap Value ETF | 7.88 |
XLV | D | SPDR Select Sector Fund - Health Care | 5.89 |
BIZD | A | Market Vectors BDC Income ETF | 5.24 |
View all Drug Delivery related ETFs...
Compare ETFs
Date | Stock | Signal | Type |
---|---|---|---|
2021-03-05 | BDSI | Hammer Candlestick | Bullish |
2021-03-05 | BDSI | Lizard Bullish | Bullish Day Trade Setup |
2021-03-05 | BDX | Crossed Above 200 DMA | Bullish |
2021-03-05 | BDX | Slingshot Bearish | Bearish Swing Setup |
2021-03-05 | DRNA | Hammer Candlestick | Bullish |
2021-03-05 | DRNA | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-03-05 | DRNA | MACD Bearish Signal Line Cross | Bearish |
2021-03-05 | DRNA | Lizard Bullish | Bullish Day Trade Setup |
2021-03-05 | DRNA | Doji - Bullish? | Reversal |
2021-03-05 | DRNA | Crossed Above 20 DMA | Bullish |
2021-03-05 | DRRX | Lizard Bullish | Bullish Day Trade Setup |
2021-03-05 | DRRX | Hammer Candlestick | Bullish |
2021-03-05 | DRRX | 200 DMA Resistance | Bearish |
2021-03-05 | DRRX | Lower Bollinger Band Walk | Weakness |
2021-03-05 | EARS | Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup |
2021-03-05 | EARS | Shooting Star Candlestick | Bearish |
2021-03-05 | EARS | Wide Range Bar | Range Expansion |
2021-03-05 | EARS | Volume Surge | Other |
2021-03-05 | EARS | Crossed Above 50 DMA | Bullish |
2021-03-05 | EARS | 20 DMA Resistance | Bearish |
2021-03-05 | EARS | Pocket Pivot | Bullish Swing Setup |
2021-03-05 | EARS | 1,2,3 Pullback Bullish | Bullish Swing Setup |
2021-03-05 | EYEG | Pocket Pivot | Bullish Swing Setup |
2021-03-05 | EYEG | Bullish Engulfing | Bullish |
2021-03-05 | HRTX | Lower Bollinger Band Walk | Weakness |
2021-03-05 | HRTX | Calm After Storm | Range Contraction |
2021-03-05 | HRTX | Stochastic Buy Signal | Bullish |
2021-03-05 | HRTX | Crossed Above 200 DMA | Bullish |
2021-03-05 | HRTX | Hammer Candlestick | Bullish |
2021-03-05 | HTGC | New Downtrend | Bearish |
2021-03-05 | HTGC | Fell Below 20 DMA | Bearish |
2021-03-05 | HTGC | 50 DMA Support | Bullish |
2021-03-05 | HTGC | Wide Range Bar | Range Expansion |
2021-03-05 | HTGC | Slingshot Bullish | Bullish Swing Setup |
2021-03-05 | HTGC | MACD Bearish Signal Line Cross | Bearish |
2021-03-05 | LCTX | Hammer Candlestick | Bullish |
2021-03-05 | LCTX | Lizard Bullish | Bullish Day Trade Setup |
2021-03-05 | LCTX | New Downtrend | Bearish |
2021-03-05 | LCTX | Lower Bollinger Band Walk | Weakness |
2021-03-05 | LDL | Upper Bollinger Band Walk | Strength |
2021-03-05 | LDL | 180 Bullish Setup | Bullish Swing Setup |
2021-03-05 | LDL | Hammer Candlestick | Bullish |
2021-03-05 | LDL | Doji - Bullish? | Reversal |
2021-03-05 | LDL | Calm After Storm | Range Contraction |
2021-03-05 | LEXX | New Downtrend | Bearish |
2021-03-05 | LEXX | Doji - Bullish? | Reversal |
2021-03-05 | MDT | Crossed Above 50 DMA | Bullish |
2021-03-05 | MDT | Crossed Above 20 DMA | Bullish |
2021-03-05 | MMM | Crossed Above 20 DMA | Bullish |
2021-03-05 | MMM | Bollinger Band Squeeze | Range Contraction |
2021-03-05 | MMM | MACD Bullish Signal Line Cross | Bullish |
2021-03-05 | NEOS | 200 DMA Support | Bullish |
2021-03-05 | PCRX | Lower Bollinger Band Walk | Weakness |
2021-03-05 | PCRX | MACD Bearish Centerline Cross | Bearish |
2021-03-05 | PCRX | Stochastic Buy Signal | Bullish |
2021-03-05 | PROG | Hammer Candlestick | Bullish |
2021-03-05 | PROG | Lower Bollinger Band Walk | Weakness |
2021-03-05 | SRDX | NR7 | Range Contraction |
2021-03-05 | SRDX | New 52 Week High | Strength |
2021-03-05 | SRDX | 180 Bullish Setup | Bullish Swing Setup |
2021-03-05 | SRDX | New 52 Week Closing High | Bullish |
2021-03-05 | TLC | Pocket Pivot | Bullish Swing Setup |
2021-03-05 | TLC | 50 DMA Resistance | Bearish |
2021-03-05 | TLC | 200 DMA Resistance | Bearish |
2021-03-05 | TPVY | Lower Bollinger Band Walk | Weakness |
2021-03-05 | TPVY | Narrow Range Bar | Range Contraction |
2021-03-05 | TTNP | New 52 Week Low | Weakness |
2021-03-05 | TTNP | Lower Bollinger Band Walk | Weakness |
2021-03-05 | TTNP | New 52 Week Closing Low | Bearish |
2021-03-05 | VRPX | New 52 Week Closing Low | Bearish |
2021-03-05 | VRPX | New 52 Week Low | Weakness |
2021-03-05 | VRPX | Hot IPO Pullback | Bullish Swing Setup |
2021-03-05 | WST | Hammer Candlestick | Bullish |
2021-03-05 | WST | Lower Bollinger Band Walk | Weakness |
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. Drug release is from: diffusion, degradation, swelling, and affinity-based mechanisms. Some of the common routes of administration include the enteral (gastrointestinal tract), parenteral (via injections), inhalation, transdermal, topical and oral routes. . Many medications such as peptide and protein, antibody, vaccine and gene based drugs, in general may not be delivered using these routes because they might be susceptible to enzymatic degradation or can not be absorbed into the systemic circulation efficiently due to molecular size and charge issues to be therapeutically effective. For this reason many protein and peptide drugs have to be delivered by injection or a nanoneedle array.
For example, many immunizations are based on the delivery of protein drugs and are often done by injection.
Current efforts in the area of drug delivery include the development of targeted delivery in which the drug is only active in the target area of the body (for example, in cancerous tissues), sustained release formulations in which the drug is released over a period of time in a controlled manner from a formulation, and methods to increase survival of peroral agents which must pass through the stomach's acidic environment. In order to achieve efficient targeted delivery, the designed system must avoid the host's defense mechanisms and circulate to its intended site of action. Types of sustained release formulations include liposomes, drug loaded biodegradable microspheres and drug polymer conjugates. Survival of agents as they pass through the stomach typically is an issue for agents which cannot be encased in a solid tablet; one research area has been around the utilization of lipid isolates from the acid-resistant archaea Sulfolobus islandicus, which confers on the order of 10% survival of liposome-encapsulated agents.
Mike's Notes
- TWLO: Here's anoth...
- ABNB: An interesti...
- CGNT: Not a chart ...
- TDOC: One of sever...
- NFLX: I love these...
From the Blog
Popular Now
Featured Articles
- What You Trade Is As Important As How You Trade
- Breakouts, Home Runs & Exponential Returns w/ Kristjan Kullamägi
- Tech Stock Indices: Do Bulls Have A Problem?
- Robinhood Proxies – The Private and Public Markets Can Be Very Connected
- The Rise of Cult Stocks
- Semi-automating Your Trading
- Recommended Stock Trading Books